Why the study?
How can the incidence of dead in bed syndrome be reduced in young people with type 1 diabetes?
How can the incidence of dead in bed syndrome be reduced in young people with type 1 diabetes?
Dead in bed syndrome in young type 1 diabetics is likely caused by nocturnal hypoglycemia-induced fatal arrhythmias, which may be mitigated by continuous glucose monitoring and screening.
Supports CGM screening for nocturnal hypoglycemia in type 1 diabetes; leaves open impact on dead-in-bed syndrome.
Dead in bed (DIB) syndrome is a poorly understood cause of sudden and mysterious death in young people with type 1 diabetes on insulin therapy. Severe nocturnal hypoglycemia with unawareness is the most plausible mechanism which precipitates fatal arrhythmia in the vulnerable individual. Avoiding recurrent hypoglycemic episodes; screening for proarrhythmic condition in high-risk people with positive family history; and using real-time continuous glucose monitoring device in those with nighttime hypoglycemia and hypoglycemia unawareness can help to reduce the incidence of this deadly condition.
No takes yet. Share an insight, caveat, or question.
Poudel et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: